has been refreshed! Take a tour.
Issue 1459: November 13, 2019









FDA approves Fluzone High-Dose Quadrivalent (Sanofi Pasteur) for adults 65+ years of age—will be available for 2020–21 flu season 

The U.S. Food and Drug Administration has approved the use of Fluzone High-Dose Quadrivalent influenza vaccine (Sanofi Pasteur) for adults 65 years of age and older. This vaccine will be available for the 2020–21 flu season. A portion of Sanofi's press release is reprinted below.

Fluzone® High-Dose (Influenza Vaccine) was approved by the FDA in 2009 as a trivalent influenza vaccine, including two influenza A strains and one influenza B strain. Fluzone High-Dose Quadrivalent contains an additional influenza B strain. Fluzone High-Dose Quadrivalent is given to people 65 years of age and older to help prevent influenza disease caused by influenza A and B strains contained in the vaccine.

Access the Sanofi press release: FDA approves Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older.

Related Links

Back to top

American Lung Association, American Diabetes Association, and American Heart Association join together to urge adults with chronic health conditions to prioritize annual flu vaccination
Three of the nation's leading nonprofit health organizations, the American Lung Association, American Diabetes Association, and American Heart Association have joined together to urge adults with chronic health conditions to prioritize annual flu vaccination and to call on healthcare professionals to strongly recommend flu vaccinations to their patients.

Read the press releases from the American Lung Association and the American Diabetes Association about this new partnership. 

Back to top

Dr. Deborah Wexler’s VEC Technically Speaking column about CDC’s updated HPV recommendations now available on

Technically Speaking is a monthly column written by Dr. Deborah Wexler, IAC’s executive director, for Vaccine Update, a monthly e-newsletter from the Vaccine Education Center (VEC) at Children's Hospital of Philadelphia (CHOP). The column covers practical topics in immunization such as vaccine administration, scheduling, and recommendations.

October's column is titled CDC Updates Recommendations on the Use of HPV Vaccine. The introductory paragraphs are reprinted below.

On August 16, CDC published updated guidance on the use of HPV vaccine, Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization.

The recommendations now include the following updated information:

  • For children and adults age 9 through 26 years: The vaccine is routinely recommended at age 11 or 12 years, but vaccination can be given starting at age 9 years. Vaccination is now recommended for all persons (both males and females) through age 26 years.
  • For males through age 26 years: As noted above, ACIP now recommends routine HPV vaccination for all persons in this age group. Previously, ACIP recommended routine vaccination for males only through age 21; for males age 22—26, vaccine was recommended only for those with risk factors or for those who wanted to be protected from the disease. ACIP has routinely recommended HPV vaccination for females through age 26 since 2007.
  • For adults age 27 through 45 years who have not been vaccinated: For this age group, ACIP recommends shared (between the provider and the patient) clinical decision making to determine whether or not a patient would benefit from receiving HPV vaccine. 

Access the complete article here.

You can find current and past issues of Technically Speaking in the following ways:

  • From the Technically Speaking display box in the middle of the home page
  • From the bottom of every web page in the "Guide to" box
  • From the Technically Speaking main page on 

To subscribe to VEC's Vaccine Update e-newsletter, go to the sign-up form.

Related Links:

Back to top

"Current Issues in Influenza," the webinar by IAC’s chief strategy officer, Dr. L.J Tan, now archived on IAC website; slide set available upon request

On October 29, Litjen (L.J) Tan, MS, PhD, IAC's chief strategy officer, presented a 1-hour webinar titled Current Issues in Influenza.

During his presentation, Dr. Tan discussed the 2018–2019 influenza season, some of its unique aspects, and the topic of vaccine effectiveness. He reviewed the importance of vaccination in preventing negative outcomes, highlighted new ACIP language regarding influenza vaccination, and discussed messaging for the 2019–2020 season.

This webinar is also available for viewing by clicking on Dr. Tan’s photo in the middle of the home page

From IAC's PowerPoint Slide Sets web page, you can:

Back to top

IAC Spotlight: IAC’s National Network for Immunization Coalitions website is the “go-to” place for information about 134 immunization coalitions across the U.S.

In 2016, IAC launched its new website for the National Network for Immunization Coalitions at The site is intended to be a one-stop shop for learning about more than 134 immunization coalitions in the U.S.—their locations, missions, activities—and about how to engage with them. The website is fully searchable by coalition name and state.

The website promotes the activities of immunization coalitions, offers resources of importance to the network, and provides a searchable online database of local, state, regional, and national immunization coalitions. Immunization supporters can find contacts, resources, ideas, and volunteer opportunities.

Every U.S. immunization coalition is encouraged to join this network and there is no cost. Network members have the opportunity to participate in free bimonthly webinars featuring national experts, to engage in conversations via a private electronic discussion group (listserv), and to sign up for the free e-newsletter, Network News.

Visit the National Network for Immunization Coalitions website to learn about immunization coalitions.

Related Links 

Back to top

Flu season is here, so make sure you have IAC's new "FLU VACCINE" buttons for staff and patient stickers on hand!

IAC's new “FLU VACCINE” buttons and stickers are ready to ship! Their bright red color helps broadcast your important message about the need for flu vaccination. And the cost is nominal.


The button measures 1.25" across and carries a bold message! Pin on lab coats, uniforms, other clothing, tote bags, or backpacks to show support for flu vaccine.
Buttons are delivered in bags of 10 buttons per bag.

Click here for pricing and ordering information for "FLU VACCINE" buttons.


Measuring 1.5" across and printed on Avery labels, theses stickers adhere well to clothing and have an easy-peel-off back.

Stickers are delivered to you cut individually (not on rolls)—available in bundles of 100. 

Click here for pricing and ordering information for “FLU VACCINE” stickers.

Visit Shop IAC for additional items, including "Vaccines Save Lives" enamel pins, patient record cards, and a vaccine administration training video.

Back to top

IAC's elegantly designed "Vaccines Save Lives" black enamel pins make great gifts for the holidays!

IAC has just designed an elegant new “Vaccines Save Lives” pin on hard black enamel with gold lettering and edges. 

The pin is a stick-through-post variety with the back end covered by a round rubber cap that holds the pin securely. A gold metal spring-lock clasp is also provided. The pin makes a refined statement, measuring 1.125" x 0.75". 

Wear these pins on clothing, uniforms, lab coats, tote bags, and backpacks to show that you value vaccines!

Click here for "Vaccines Save Lives" pins pricing and ordering information.

Visit Shop IAC for additional items, including "FLU VACCINE" buttons and stickers, patient record cards, and a vaccine administration training video.

Back to top


IAC updates its Declination of Influenza Vaccination form for healthcare personnel

IAC recently revised its Declination of Influenza Vaccination form to enumerate the reasons why all healthcare personnel who do not have medical contraindications should be vaccinated.

Access all of IAC's influenza handouts for healthcare providers and their patients.

Related Links

Back to top


Influenza season has begun; check out these resources and make sure all your patients are getting vaccinated!

Influenza season has now begun. Nationally, flu activity is low but increasing, and Louisiana and Puerto Rico are both continuing to experience high levels of influenza-like illness. Two influenza-associated pediatric deaths were reported to CDC during the week ending October 19; no new influenza-related pediatric deaths were reported during the week ending November 2.

Visit the CDC’s Weekly U.S. Influenza Surveillance Report, FluView, for details.

Influenza vaccination is recommended for everyone six months of age and older, so please continue to vaccinate all your patients in this age range. If you don't provide influenza vaccination in your clinic, please recommend vaccination to your patients and refer them to a clinic or pharmacy that provides vaccines or to the HealthMap Vaccine Finder to locate influenza vaccination services near them.

Related Links:

Back to top

IAC's comprehensive Vaccinating Adults: A Step-by-Step Guide is available for free download either by chapter or in its entirety (142 pages)

In late 2017, the Immunization Action Coalition (IAC) announced the publication of its new book, Vaccinating Adults: A Step-by-Step Guide (Guide).

This completely updated "how to" guide on adult immunization provides easy-to-use, practical information covering essential adult immunization activities. It helps vaccine providers enhance their existing adult immunization services or introduce them into any clinical setting. Topics include:

  • setting up for vaccination services,
  • storing and handling vaccines,
  • deciding which people should receive which vaccines,
  • administering vaccines,
  • documenting vaccinations (including legal issues), and
  • understanding financial considerations and billing information.

In addition, the Guide is filled with hundreds of web addresses and references to help providers stay up to date on the latest immunization information, both now and in the future.

The Guide is available to download/print either by chapter or in its entirety free of charge at The downloaded version is suitable for double-sided printing. The National Vaccine Program Office and CDC both supported the development of the Guide and provided early technical review.

The Guide is a uniquely valuable resource to assist providers in increasing adult immunization rates. Be sure to get a copy today!

Related Links

Back to top


October issue of CDC's Immunization Works newsletter now available

CDC recently released the October issue of its monthly newsletter Immunization Works. The newsletter offers the immunization community information about current topics. The information is in the public domain and can be reproduced and circulated widely.

Related Links

Back to top


Registration is open for the Epidemiology & Prevention of Vaccine-Preventable Diseases ("The Pink Book") course in Indiana, April 14–15

CDC faculty from its National Center for Immunization and Respiratory Diseases will present a comprehensive review of immunization principles and recommendations. This 2-day continuing education course, Epidemiology and Prevention of Vaccine Preventable Diseases ("The Pink Book"), will be hosted by the Indiana Immunization Coalition on April 14–15 in Plainfield, IN.

Registration information

Related Link


NFID invites abstract submissions by December 18 for its 2020 Annual Conference on Vaccinology Research, March 23–25 in Washington, DC

The National Foundation for Infectious Diseases (NFID) is inviting abstracts for its 2020 Annual Conference on Vaccinology Research (ACVR), which will be held March 23–25 in Washington, DC. The deadline for submitting an abstract is December 18, 2019.

Access additional information on the 2020 Annual Conference on Vaccinology Research (ACVR) Call for Abstracts web page.

Access the ACVR abstract submission site.

Related Links

Back to top

About IAC Express
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue.

If you have trouble receiving or displaying IAC Express messages, visit our online help section.

IAC Express is supported in part by Grant No. 6NH23IP922550 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC. IAC Express is also supported by educational grants from the following companies: AstraZeneca, Inc.; Merck Sharp & Dohme Corp.; Pfizer, Inc.; and Sanofi Pasteur.

IAC Express Disclaimer
ISSN: 1526-1786
Our mailing address is
Immunization Action Coalition
2550 University Avenue West, Suite 415 North
Saint Paul, MN 55114

Copyright (C) 2019 Immunization Action Coalition
All rights reserved.

About IZ Express

IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

Editorial Information

  • Editor-in-Chief
    Kelly L. Moore, MD, MPH
  • Managing Editor
    John D. Grabenstein, RPh, PhD
  • Associate Editor
    Sharon G. Humiston, MD, MPH
  • Writer/Publication Coordinator
    Taryn Chapman, MS
    Courtnay Londo, MA
  • Style and Copy Editor
    Marian Deegan, JD
  • Web Edition Managers
    Arkady Shakhnovich
    Jermaine Royes
  • Contributing Writer
    Laurel H. Wood, MPA
  • Technical Reviewer
    Kayla Ohlde

This page was updated on .